Search

everythinglearnresearchcommunity

for

Search:↓

Gefitinib and Sasam-Kyeongokgo together significantly reduce cancer growth and improve immune response in mice.

A mother's iron levels early in pregnancy can influence the DNA makeup of her child, potentially affecting the child's health.

The traditional herbal formulas Yongdamsagan-Tang and Paljung-san, along with the drug finasteride, can reduce inflammation and may work together without affecting each other's effectiveness against benign prostatic hyperplasia.

Propylthiouracil can cause hair loss, reduced sweating, and nail issues, but stopping the drug can reverse hair and nail problems.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

The research suggests that the ZP4 gene is linked to egg development in women with PCOS but requires more study to understand its role in infertility.

Aldesleukin can treat certain cancers and increase HIV patient CD4+ counts but often causes severe side effects.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Low serum complement levels in SLE patients don't always match with disease flares; monitoring C3 and C4 is useful, but cell-bound complement products might better indicate disease activity.

The document concludes that careful evaluation is key to diagnose and treat women with hair loss, with tests for thyroid, iron, and hormones as needed.

A new mutation in the STING protein causes a range of symptoms and its severity may be affected by other genetic variations; treatment with a specific inhibitor showed improvement in one patient.

Recognizing the different stages of alopecia areata is crucial for accurate diagnosis and treatment.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Antioxidants can help improve hair growth in people with alopecia areata.

The document concludes that an experimental drug may help wound healing in Epidermolysis Bullosa, links Hydroa vacciniforme to EBV, discusses diagnosing hair loss disorders, finds many children with eczema have allergies, reviews the safety of a skin medication in children, notes side effects of a Duchenne's treatment, and identifies a marker for pediatric mastocytosis.

Low energy laser therapy effectively treats certain skin conditions and improves recovery time without side effects.

DAVID syndrome is a condition with immune system and hormone deficiencies, needing early diagnosis to avoid serious complications.

Some cases of folliculotropic mycosis fungoides may progress slowly and not need aggressive treatment.

Nivolumab can cause hair loss as a rare side effect.

Ayurvedic treatments can improve symptoms and quality of life for systemic sclerosis patients.

Stem-cell therapy shows promise for skin conditions but needs more research.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Low-energy laser therapy can improve scalp alopecia treatment when combined with classical methods.

Cytotoxic T cells cause hair loss in chronic alopecia areata.

Understanding drug interactions, side effects, and patient-specific factors is crucial for effective dermatological care.

Fat from the body can help improve hair growth and scars when used in skin treatments.

Certain types of T cells are essential for healthy skin and play a role in skin diseases, but more research is needed to improve treatments.

Deleting Snai2 and Snai3 causes fatal autoimmunity.

The vitamin D receptor is involved in multiple body functions beyond calcium regulation, including immune response and rapid reactions not related to gene activity.